- Home
- BDSX vs EAF Comparison
BDSX vs EAF Comparison
Compare BDSX & EAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDSX
- EAF
- Stock Information
- Founded
- BDSX 2005
- EAF 1886
- Country
- BDSX United States
- EAF United States
- Employees
- BDSX N/A
- EAF N/A
- Industry
- BDSX Precision Instruments
- EAF Industrial Machinery/Components
- Sector
- BDSX Health Care
- EAF Energy
- Exchange
- BDSX Nasdaq
- EAF Nasdaq
- Market Cap
- BDSX 245.3M
- EAF 215.0M
- IPO Year
- BDSX 2020
- EAF 1995
- Fundamental
- Price
- BDSX $1.60
- EAF $1.76
- Analyst Decision
- BDSX Strong Buy
- EAF Hold
- Analyst Count
- BDSX 4
- EAF 5
- Target Price
- BDSX $3.08
- EAF $1.75
- AVG Volume (30 Days)
- BDSX 118.2K
- EAF 2.7M
- Earning Date
- BDSX 11-01-2024
- EAF 11-01-2024
- Dividend Yield
- BDSX N/A
- EAF N/A
- EPS Growth
- BDSX N/A
- EAF N/A
- EPS
- BDSX N/A
- EAF N/A
- Revenue
- BDSX $60,902,000.00
- EAF $570,048,000.00
- Revenue This Year
- BDSX $48.06
- EAF N/A
- Revenue Next Year
- BDSX $29.97
- EAF $9.19
- P/E Ratio
- BDSX N/A
- EAF N/A
- Revenue Growth
- BDSX 46.25
- EAF N/A
- 52 Week Low
- BDSX $1.15
- EAF $0.52
- 52 Week High
- BDSX $2.21
- EAF $3.54
- Technical
- Relative Strength Index (RSI)
- BDSX 39.90
- EAF 70.15
- Support Level
- BDSX $1.59
- EAF $1.40
- Resistance Level
- BDSX $1.68
- EAF $2.05
- Average True Range (ATR)
- BDSX 0.06
- EAF 0.18
- MACD
- BDSX -0.01
- EAF 0.00
- Stochastic Oscillator
- BDSX 20.51
- EAF 60.14
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
About EAF GrafTech International Ltd.
GrafTech International Ltd is a manufacturer of high-quality graphite electrode products essential to the production of EAF steel and other ferrous and non-ferrous metals. The company has only reportable segment, Industrial Materials, is comprised of its two major product categories: graphite electrodes and petroleum needle coke products. Petroleum needle coke is key raw material used in the production of graphite electrodes.